Simple dosing with INGREZZA
Always one capsule, once a day
Taken any time
With or without food
INGREZZA is available in 3 effective dosages.
The recommended dose of INGREZZA is 80 mg. Your healthcare provider will start you on 40 mg for 1 week and may keep you on 40 mg, or switch you to 60 mg or 80 mg, depending on your treatment needs.
Your healthcare provider will tell you what dose of INGREZZA to take and when to take it.
INGREZZA® (valbenazine) capsules can be taken with or without food.
- Do not stop taking INGREZZA without talking to your healthcare provider first
- If you take too much INGREZZA, call your poison control center at 1-800-222-1222
Do not take INGREZZA if you’re allergic to valbenazine or any of its ingredients.
INGREZZA and your mental health
In a clinical study, psychiatric status remained stable overall in people taking INGREZZA for TD, including those who were also taking medicine for:
- Bipolar disorder
- Schizophrenia/schizoaffective disorder
- Anxiety disorder
People taking INGREZZA for TD can stay on their current dose of most mental health medicines.
Tell your healthcare provider about all the medicines you take, including:
- Prescription medicines
- Over-the-counter medicines
- Herbal supplements
Do not start any new medicines while taking INGREZZA without talking to your healthcare provider first.
Before taking INGREZZA, tell your healthcare provider about all of your medical conditions, including if you:
have liver or heart problems, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking INGREZZA with certain other medicines may cause serious side effects.
“I’m grateful that I found INGREZZA and that it’s working well for me. My hope is to become more open about my struggles with mental illness and TD.”
Individual results may vary
– Moira, living with depression and tardive dyskinesia
Moira was compensated by Neurocrine Biosciences, Inc. to share her story